Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage?

Dermatology

Volumn 192, Issue 2, 1996, Pages 89-93

  Schadendorf, D ^a   Diehl, S ^a   Zuberbier, T ^a   Schadendorf, C ^a   Henz, B M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Intercellular adhesion molecule 1; P selectin; Prognosis; Tumour progression

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 0030030109     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246328     Document Type: Article

References (30)

1. New cancer statistics, show losses, gains. J Natl Cancer Inst 1990:82:138-140.
2. Altman DL, Creagan ET. Hahn RG. Edmonson JH, Bisel HE Schaid DJ: Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer 1989;63:224-227.
3. Batch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH: An analysis of prognostic factors in 8.500 patients with cutaneous melanoma: in Balch CM. Houghton AN, Milton GW. Sober AJ. Soong SJ (eds): Cutaneous Melanoma. Philadelphia. Lippincott, 1992, pp 165-187.
4. Armstrong BK. English DR: Epidemiologic studies; in Balch CM, Houghton AN. Milton GW, Sober AJ, Soong SJ (eds): Cutaneous Melanoma. Philadelphia. Lippincott. 1992. pp 12-39.
5. Banks RE. Gearing AJH. Hemingway IK. Norfolk DR. Perron TJ. Selby PJ: Circulating intracellular adhesion molccule-l (ICAM-1). E-selectin and vascular adhesion molecule-1 (VCAM-I) in human malignancies. Br J Cancer 1993;68:122-124.
6. Gearing AJH. Newman W: Circulating adhesion molecules in disease. Immunol Today 1993:14:506-512.
7. Altomonte M. Colizzi F, Esposito G. Maio M: Circulating intercellular adhesion molecule-1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1991:327:959.
8. Harning R, Mainolfi E. Bystryn JC. Henn M. Merluzzi VJ, Rothlein R: Scrum levels of circulating intercellular adhesion molecule-1 in human malignant melanoma. Cancer Res 1990;51:5003-5005.
9. Seth R. Raymond FD, Makoba MW: Circulating ICAM-I isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-84.
10. Liotta LA, Stctlcr-Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 1991: 51:5054s-5059s.
11. Albelda SM, Mette SA. Elder DE. Stewart R. Damjanovich L. Herlyn M. Buck CA: Integrin distribution in malignant melanoma: Association of the 15, subunit with tumor progression. Cancer Res 1990:50:6757-6764.
12. Hart IR. Birch M. Marshall JF: Cell adhesion receptor expression during melanoma progression and melastatis. Cancer Metastasis Rev 1991;10:115-128.
13. Moretti S. Martini L, Berti E. Pinzi C. Gian-notti B: Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 1993:3:235 -239.
14. Albelda SM. Buck CA: Intcgrins and other cell adhesion molecules. FASEB J 1990:4: 2868-2880.
15. Schadendorf D. Gawlik C. Haney U. Ostmeier H, Sutcr L. Czarnetzki BM: Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 1993:170:429-434.
16. Schadendorf D. Heidel J. Gawlik C. Suter L. Czarnetzki BM: Association of the expression of VLA-4 on primary cutaneous malignant melanoma and ELAM-1 and CD62 intralu-moral vessels with clinical outcome. J Natl Cancer Inst 1995:87:366-371.
17. Takamatsu K, Auerbach B. Gerardy-Schahn R. Eckhardt M. Jaques G. Madry N: Characterization of tumor-associated neural cell adhesion molecule in human serum. Cancer Res 1994: 54:2598-2603.
18. Kageshita T. Yoshii A. Kimura T. Kuriya N. Ono T. Tsujisaki M. Imai K. Fcrrone S: Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993:53: 4927-4932.
19. de Paoli P. D’Andrea M. Santini G. Zagoncl V. Pinto A. Carbone A: Serum levels of adhesion molecules in haematopoietic tumours (letter). Immunol Today 1994:15:339.
20. Johnson JP. Stade BG. Holzmann B. Schwablc W, Rielhmuller G: De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sei USA 1989:86:641-644.
21. Koijima T. Ono A. Aoki T. Kamcda-Hayashi N, Kobayashi Y: Circulating ICAM-I levels in children with atopic dermatitis. Ann Allergy 1994:73:351-355.
22. Scheibenbogen C, Keilholz U, Meuer S. Den-gler T, Tilgen W. Hunstein W: Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Im J Cancer 1993: 54:494-498.
23. Becker JC. Dummer R. Hartmann AA. Burg G. Schmidt RE: Shedding of ICAM-I from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. J Immunol 1991: 147:4398-4401.
24. Chong BH. Murray B. Berndt MC. Dunlop LC. Brighton T, Chesterman CN: Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994:83:1535 -1541.
25. Dunlop LC. Skinner MP. Bendall LJ. Favaloro J. Castaldi PA. Gorman JJ. Gamble JR. Vadas MA. Berndt MC: Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992:175:1147-1150.
26. Herrlich P. Zöller M. Pals ST. Ponta H: CD44 splice variants: Métastasés meet lymphocytes. Immunol Today 1993:14:395-399.
27. Matsumura Y. Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992:340:1053-1058.
28. Seitcr S. Schadendorf D. Herrmann K. Schneider M. Rose I M. Arch R. Tilgen W. Zöller M: Expression of the epithelial isoform of CD44 on malignant melanoma. Clin Cancer Res 1995: in press.
29. Rice GE, Bevilacqua MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989:246: 1303-1305.
30. Pigolt R. Dillon LP. Hemingway IH. Gearing AJH: Soluble forms of E-selectin. ICAM-I and VCAM-I arc present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992:187: 584-589